PIC/S agrees to share with WHO, adds members, mulls FDA application
This article was originally published in The Gold Sheet
Executive Summary
The Pharmaceutical Inspection Cooperation Scheme May 27 reached agreement with the World Health Organization's team for quality assurance and safety and its team for biologicals and medicines on an agreement to cooperate in the areas of training inspectors and sharing documents. The international group of pharmaceutical inspection agencies has grown from its core in Europe to include agencies from 37 countries around the world including Lithuania, which joined this month. Iran has asked to join, and there are signs of interest from Japan, Brazil, Russia and New Zealand. According to the minutes, there was talk at its latest meeting in early May of establishing a second-tier category for inspection authorities in countries such as India and China that are not yet competent enough for full membership. Meanwhile, FDA's application to join is still pending, with an audit of the agency expected later this year
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.